[1]
D. T. N., R. B. C., and K. K. N., “Mortality and survival benefits in people living with human immunodeficiency virus initiated newly with Antiretroviral therapy irrespective of CD4 count”, Int J Adv Med, vol. 7, no. 2, pp. 272–275, Jan. 2020.